Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Mikepalon Mar 08, 2017 8:52am

186 Views

Post# 25949266

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:pumpers

I have refrained on commenting to your BS on this BB - had enough of your BS on the LAG board - you ride her up like the rest of the traders but, you have the inside track to bash her down so you can re-enter - your great for business - like I said on the other BBs I am going to just follow you around - you reduce my time re: studying charts and other DD - you taking this down to .10 again? I am buying again if you do.....

Bullboard Posts

The top 10 Canadian medical stocks